In the cortex, delphinidin showed a slight decreasing trend in GFAP protein levels, but this did not reach statistical significance (Fig. 4 D-F).
← all excerpts
Delphinidin attenuates cognitive deficits and pathology of Alzheimer's disease by preventing microglial senescence via AMPK/SIRT1 pathway.
1
—
—